Yang H
Cells. 2025; 14(4).
PMID: 39996748
PMC: 11853439.
DOI: 10.3390/cells14040276.
Bindra S, Mostafa E, Abdelgawad M, Selim S, Kumar S, Mathew B
RSC Med Chem. 2025; .
PMID: 39925735
PMC: 11799932.
DOI: 10.1039/d4md00837e.
Yoo J, Lee J, Ahn B, Han J, Lim M
Chem Sci. 2025; 16(5):2105-2135.
PMID: 39810997
PMC: 11726323.
DOI: 10.1039/d4sc06762b.
Ogos M, Stary D, Bajda M
Int J Mol Sci. 2025; 26(1.
PMID: 39796014
PMC: 11720639.
DOI: 10.3390/ijms26010157.
Vahid Z, Eskandani M, Dadashi H, Vandghanooni S, Rashidi M
Heliyon. 2024; 10(23):e40756.
PMID: 39717593
PMC: 11664286.
DOI: 10.1016/j.heliyon.2024.e40756.
Conjugates of amiridine and salicylic derivatives as promising multifunctional CNS agents for potential treatment of Alzheimer's disease.
Makhaeva G, Grishchenko M, Kovaleva N, Boltneva N, Rudakova E, Astakhova T
Arch Pharm (Weinheim). 2024; 358(1):e2400819.
PMID: 39686878
PMC: 11650361.
DOI: 10.1002/ardp.202400819.
Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer's Disease, a Potential Therapeutic Target.
Puranik N, Song M
Molecules. 2024; 29(23).
PMID: 39683904
PMC: 11643865.
DOI: 10.3390/molecules29235744.
Neuroprotective Potential of Aminonaphthoquinone Derivatives Against Amyloid Beta-Induced Neuronal Cell Death Through Modulation of SIRT1 and BACE1.
Apiraksattayakul S, Pingaew R, Prachayasittikul V, Ruankham W, Tantimongcolwat T, Prachayasittikul V
Neurochem Res. 2024; 50(1):50.
PMID: 39644364
PMC: 11625074.
DOI: 10.1007/s11064-024-04281-y.
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer's Disease Treatment.
Angelova V, Stoyanov B, Simeonova R
Molecules. 2024; 29(22).
PMID: 39598703
PMC: 11596391.
DOI: 10.3390/molecules29225314.
Metabolomics-driven approaches for identifying therapeutic targets in drug discovery.
Pan S, Yin L, Liu J, Tong J, Wang Z, Zhao J
MedComm (2020). 2024; 5(11):e792.
PMID: 39534557
PMC: 11555024.
DOI: 10.1002/mco2.792.
Multifunctional, Fluorene-Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease.
Panek D, Pasieka A, Jonczyk J, Gawlinska M, Zareba P, Siwek A
Angew Chem Int Ed Engl. 2024; 64(6):e202420510.
PMID: 39523866
PMC: 11796312.
DOI: 10.1002/anie.202420510.
Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.
Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L
Signal Transduct Target Ther. 2024; 9(1):211.
PMID: 39174535
PMC: 11344989.
DOI: 10.1038/s41392-024-01911-3.
Unveiling the potential of novel indol-3-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors: a combined , synthesis and study.
Sharma A, Rudrawar S, Sharma A, Bharate S, Jadhav H
RSC Adv. 2024; 14(33):23853-23872.
PMID: 39081657
PMC: 11287240.
DOI: 10.1039/d4ra04315d.
Effectiveness of Flavonoid-Rich Diet in Alleviating Symptoms of Neurodegenerative Diseases.
Szulc A, Wisniewska K, Zabinska M, Gaffke L, Szota M, Olendzka Z
Foods. 2024; 13(12).
PMID: 38928874
PMC: 11202533.
DOI: 10.3390/foods13121931.
Exploring the Mechanism of Zhishi-Xiebai-Guizhi Decoction for the Treatment of Hypoxic Pulmonary Hypertension based on Network Pharmacology and Experimental Analyses.
Huang P, Wang Y, Liu C, Zhang Q, Ma Y, Liu H
Curr Pharm Des. 2024; 30(26):2059-2074.
PMID: 38867532
DOI: 10.2174/0113816128293601240523063527.
Design, Synthesis, and Biological Evaluation of Novel Tetrahydroacridin Hybrids with Sulfur-Inserted Linkers as Potential Multitarget Agents for Alzheimer's Disease.
Wu X, Ze X, Qin S, Zhang B, Li X, Gong Q
Molecules. 2024; 29(8).
PMID: 38675602
PMC: 11051924.
DOI: 10.3390/molecules29081782.
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases.
tintas M, Peauger L, Barre A, Papamicael C, Besson T, Sopkova-de Oliveira Santos J
RSC Med Chem. 2024; 15(3):963-980.
PMID: 38516603
PMC: 10953492.
DOI: 10.1039/d3md00708a.
Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease.
Drakontaeidi A, Pontiki E
Int J Mol Sci. 2024; 25(1).
PMID: 38203753
PMC: 10778916.
DOI: 10.3390/ijms25010582.
Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics.
Dhapola R, Beura S, Sharma P, Singh S, HariKrishnaReddy D
Mol Biol Rep. 2024; 51(1):48.
PMID: 38165499
DOI: 10.1007/s11033-023-09021-z.
Isoxazole analogues of dibenzazepine as possible leads against ulcers and skin disease: and exploration.
Khan M, Ahsan Halim S, Shah L, Khan A, Ahmed I, Abdalla A
Saudi Pharm J. 2023; 31(12):101877.
PMID: 38075546
PMC: 10700390.
DOI: 10.1016/j.jsps.2023.101877.